A leading healthcare and medical technology hub in Asia. Curative's founding market and regional base, serving ophthalmology, medical aesthetics and digital dentistry.
Singapore is a high-income, internationally connected economy with an advanced healthcare system and strong regulatory standards. Its total population reached approximately 6.11 million in June 2025, supported by a diverse resident and international community.
The country serves as an important regional centre for healthcare, biomedical sciences, clinical education and medical technology. Singapore's ageing population and continued expansion of healthcare capacity are driving demand for specialist care, efficient clinical workflows and innovative healthcare solutions.
Curative Singapore operates across ophthalmology, medical aesthetics and digital dentistry, serving hospitals, specialist centres and private clinics with differentiated healthcare technologies.
Singapore has a sophisticated and highly regulated medical-device market. Healthcare institutions place strong emphasis on clinical evidence, product quality, regulatory compliance, dependable supply and local technical support.
The public healthcare sector offers significant institutional opportunities, while private hospitals and specialist clinics provide a market for differentiated and higher-value technologies.
Singapore has a mature and competitive medical-aesthetics market supported by high consumer awareness and a broad network of aesthetic clinics, dermatologists and plastic surgeons.
Demand is increasingly focused on skin quality, regenerative treatments, natural-looking results, combination protocols and clinically supported skincare.
Singapore's dental sector includes public institutions, specialist centres, independent clinics and expanding dental groups. Clinics are increasingly adopting digital technologies to improve diagnosis, treatment planning, patient communication and restorative workflows.
Singapore is Curative Group's founding market and a central platform for our regional operations. Curative Group Pte. Ltd. is incorporated in Singapore and supports healthcare institutions and professionals across ophthalmology, medical aesthetics and dentistry.
The Singapore market also provides an important base for clinical evaluation, reference-site development and the regional introduction of healthcare technologies across Southeast Asia and beyond.
Curative distributes specialist healthcare technologies across three divisions in Singapore. Product availability is subject to local regulatory status. Contact the Singapore team for current product lists and availability.
Intraocular lenses, cataract surgery consumables, ophthalmic viscoelastic devices, vitreoretinal surgical products, reusable instruments and custom procedure solutions.
Professional dermocosmetics, 3D facial scanning, aesthetic needles and cannulas, and injection-support products for aesthetic clinics, dermatologists and plastic surgeons.
Intraoral scanners, 3D facial scanners, dental milling, CAD/CAM, implant workflow solutions and dental biomaterials for modern dental practices.
References
Singapore Department of Statistics — Singapore Economy and National Accounts
National Population and Talent Division — Population in Brief 2025
Ministry of Health Singapore — Healthcare Capacity and Workforce Development
Health Sciences Authority — Medical Device Regulatory Overview
Speak with the Singapore team about product demonstrations, clinical evaluations and supply arrangements.